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Abstract
Background: The link between early blood- brain barrier (BBB) breakdown and endothelial cell activation in acute
stroke remain poorly defined. We hypothesized that P-selectin, a mediator of the early phase of leukocyte
recruitment in acute ischemia is also a major contributor to early BBB dysfunction following stroke. This was
investigated by examining the relationship between BBB alterations following transient ischemic stroke and
expression of cellular adhesion molecule P-selectin using a combination of magnetic resonance molecular imaging
(MRMI), intravital microscopy and immunohistochemistry. MRMI was performed using the contrast, gadolinium
diethylenetriaminepentaacetic acid (Gd-DTPA) conjugated to Sialyl Lewis X (Sle
x) where the latter is known to bind
to activated endothelium via E- or P selectins. Middle cerebral artery occlusion was induced in male C57/BL 6 wild-
type (WT) mice and P-selectin-knockout (KO) mice. At 24 hours following middle cerebral artery occlusion, T1 maps
were acquired prior to and following contrast injection. In addition to measuring P- and E-selectin expression in
brain homogenates, alterations in BBB function were determined immunohistochemically by assessing the
extravasation of immunoglobulin G (IgG) or staining for polymorphonuclear (PMN) leukocytes. In vivo assessment of
BBB dysfunction was also investigated optically using intravital microscopy of the pial circulation following the
injection of Fluorescein Isothiocyanate (FITC)-dextran (MW 2000 kDa).
Results: MRI confirmed similar infarct sizes and T1 values at 24 hours following stroke for both WT and KO animals.
However, the blood to brain transfer constant for Gd DTPA (Kgd) demonstrated greater tissue extravasation of Gd
DTPA in WT animals than KO mice (P < 0.03). In the P selectin KO mice, Δ T1 stroke -Δ T1 contralateral control
cortex, decreased significantly in the Gd-DTPA(sLe
X) group compared to Gd-DTPA, indicative of sLe
X mediated
accumulation of the targeted contrast agent. Regarding BBB function, in the P-selectin KO mice compared to WT
control mice, there was an attenuation in the extravasation of IgG (P < 0.001), a trend for decreased FITC
extravasation and less infiltration of PMN leukocytes (P < 0.001) thereby supporting the observed increase in Kgd
permeability in stroke brain of WT compared to KO mice.
Conclusion: P-selectin expression contributes to enhanced BBB dysfunction at 24 hours after transient focal
cerebral ischemia.
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Leukocyte recruitment occurs after ischemia/reperfusion
resulting in local tissue damage and compromised
microvascular perfusion. Central to this process is the
vascular endothelium expression of P- and E-selectin in
the first few minutes to hours after cerebral ischemia,
leading to polymorphonuclear (PMN) leukocyte or neu-
trophil migration into brain tissue, cytokine release and
free radical-mediated damage [1]. During this time,
blood brain barrier (BBB) injury can lead to an increase
in vascular permeability and brain edema, exacerbating
the initial ischemic injury [2]. Although neuroinflamma-
tory processes contribute to BBB breakdown in many
conditions [3], the link between early BBB dysfunction
and endothelial cell activation in acute stroke is unclear.
There is evidence that the inhibition of selectin adhesion
molecules reduces brain injury and inhibits neutrophil
and platelet accumulation after focal ischemia in mice
[4,5], but the mechanisms involved in this protection
remain speculative [6].
We hypothesized that since there is evidence that P-
selectin is a mediator of the early phase of leukocyte
recruitment in acute ischemia it is also a major contri-
butor to enhancing the early BBB dysfunction following
stroke. Thus, we compared alterations in BBB perme-
ability 24 hours following transient focal cerebral ische-
mia in wild type (WT) control mice to those in P-
selectin knockout (KO) mice. The results demonstrate
that following stroke P-select i ne x p r e s s i o nc o n t r i b u t e s
to BBB injury as detected using a combination of mag-
netic resonance molecular imaging (MRMI), intravital
microscopy and immunohistochemical methods. MRMI
was performed using gadolinium (Gd) diethylenetriami-
nepentaacetic acid (DTPA) conjugated to a Sialyl Lewis
X (Slex) - a mimetic of P-selectin glycoprotein ligand-1
tetrasaccharide sialyl Lewis X which mediates the bind-
ing of leukocytes and platelets to activated endothelium
[7,8].
Methods
Animal Preparation
All animal procedures were approved by the Animal
Care Committees at the University of Calgary and the
National Research Council of Canada. Transient middle
cerebral artery occlusion of 30 minutes duration was
induced in thirty four 30-35 gram male C57/BL 6 wild-
type mice or 29 P-selectin-deficient or knockout mice
(Jackson Laboratory) using the intraluminal suture
occlusion method as described previously [9]. Control
animals with sham surgery included all surgical steps
except for middle cerebral artery occlusion (n = 8).
Temperature regulation during ischemia and reperfusion
was achieved using an intra-abdominal telemetry probe
(Data Sciences International) with feedback to a heating
pad to remove the potentially confounding influence of
hypothermia during the reperfusion period. At 24 hours,
the intra-abdominal probe was removed under aseptic
conditions and temperature was then regulated by feed-
back from a rectal temperature probe during any subse-
quent procedures.
Magnetic Resonance Imaging
At 24 hours after stroke, animals were anesthetised with
isoflurane for magnetic resonance (MR) imaging using a
9.4 T MR system equipped with a Bruker Avance con-
sole as described previously [9]. Briefly, T2 scans were
acquired using a spin-echo sequence with a 2 × 2 cm
2
field of view, a 256 × 128 data matrix, a repetition time
of 2750 ms and 24 echoes with 10 msec echo-spacing
for 8 slices 1 mm thick. T1 scans were acquired using a
Contrast FAST sequence with a 2.5 × 2.5 cm
2 field of
view, a 128 × 128 data matrix, a repetition time of 3.5
ms, an echo time of 2 msec, a flip angle of 12° and 20
inversion time points for one 1 mm thick slice through
the infarct. T1 and T2 maps were determined using local
imaging software (Marevisi, National Research Council).
For the experimental protocol, T1 and T2 scans were
first acquired prior to contrast injection. Then, either
DTPA (molecular weight 938 g/mol) or targeted con-
trast agent using a mimetic of Sialyl Lewis
X, coupled to
Gd-DTPA (Gd-DTPA-(sLeX), molecular weight 1758 g/
mol) was injected intravenously at a dose of 0.1 mmol
Gd/kg body weight. Subsequently, T1 maps were
acquired every 11 minutes for 55 minutes to allow Gd-
DTPA-(sLeX) to bind to its target and to allow non-tar-
geted (Gd-DTPA) contrast to at least partially clear
from the circulation.
The first 33 minutes post injection was used to assess
blood-brain barrier function by determining the transfer
constant for Gd-DTPA into the brain (KGd). KGd was
calculated using T1 measures in the sagittal sinus and in
regions of interest using a Patlak plot similar to that
described by Ewing et al [10]. The regions of interest
included the parietal cortex in the infarct core and the
equivalent contralateral control cortex. T1 maps were
also used to determine targeted contrast binding by cal-
culating the quantity Δ T1 Stroke - Δ T1 Control Hemi-
sphere which was defined as: [Post - pre-contrast mean
T1 value of the stroke region] - [Post - pre-contrast
mean T1 value of a corresponding region in the contral-
ateral cortex]. After imaging, the animals were eutha-
nized by intracardiac injection of sodium pentobarbital
(70 mg/kg).
Infarct areas and volumes were calculated using the
T2 MR images. The infarct area in each T2 slice was
readily apparent as a region of increased T2.T h ec a l c u -
lation of the infarct area included a measure of the
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exception of the ventricles) having a T2 value greater
than a threshold of 2 standard deviations above the
mean T2 in the contralateral cortex. For each slice, the
infarct area was corrected for edema (Ipsilateral infarct
area (uncorrected)/((Ipsilateral hemisphere area/Contral-
ateral hemisphere area)), and from this, the radius of
this area was derived. Then the infarct and ipsilateral
hemispheric volume between slices was calculated by
the cone frustum volume approximation and the infarct
and hemispheric tip volumes anteriorly and posteriorly
w e r ec a l c u l a t e db yt h ec o n ev o l u m ea p p r o x i m a t i o n
[11,12].
Protein and Immunohistochemical Tissue Analyses
P- and E-selectin expression was measured in samples of
cortical tissue homogenates from the hemispheres con-
tralateral and ipsilateral to the infarct. These levels were
quantified using commercially available enzyme-linked
immunosorbent assay (ELISA) kits (Quantikine sP-selec-
tin or sE-selectin ELISA Kit, R&D Systems). Total pro-
tein in each sample was determined by the modified
Lowry assay method.
After 24 h, animals were injected with an overdose of
sodium pentobarbital and perfused transcardially with
0.1 M phosphate buffered saline followed by 4% parafor-
maldehyde. Brains were removed, dehydrated and
embedded in paraffin blocks. Serial coronal paraffin sec-
tions (10 μm) thick were cut and stained with hematox-
ylin and eosin for identification of infarcted tissue.
T h ep r e s e n c eo fs y s t e m i ci m m u n o g l o b u l i nG( I g G )
within brain was assessed immunohistochemically in 10
μm thick paraffin embedded coronal sections cut at the
level of bregma +1.2 mm. Sections were stained with
goat anti-mouse IgG antibody (1:200 concentration),
using horseradish peroxidase-streptavidin (1:400 concen-
tration) and diaminobenzidine for visualization. Sections
from multiple treatment groups were processed together
using standardized techniques for staining and measure-
ment. Relative staining intensity was assessed using an
Olympus BX 61 light microscope at 1.5× magnification.
Intensity for IgG staining was quantified taking the grey
levels of the darkest region in the ischemic hemisphere
and subtracting it from the grey values measured in the
corresponding region of darkest intensity in the contral-
ateral hemisphere. With increasing BBB injury IgG
extravasation increased resulting in darker staining and
lower grey levels.
Immunohistochemical staining for polymorphonuclear
(PMN) leukocytes was done on 30 μm thick cryostat
sections of brain. The sections were washed in PBS initi-
ally and between all incubations. First, sections were
blocked for endogenous peroxidases by incubating with
am i x t u r eo fH 2O2 and methanol (3:27) for 15 min.
Then the sections were blocked with 10% normal goat
serum for 1 h at room temperature and incubated with
a mouse monoclonal antibody to granulocytes (Abcam,
Cambridge, MA, USA; 1:150) overnight at 4°C. Subse-
quently, sections were incubated with anti-mouse bioti-
nylated secondary antibody (Vectastain ABC Kit, Vector
Labs, Burlingame, CA, USA) for 1.5 h at room tempera-
ture and incubated with Vectastain ABC reagent (Vec-
tastain ABC kit, Vector Labs, Burlingame, CA, USA) for
30 min at room temperature. The sections were incu-
bated with 3, 3’ diaminobenzidine tetrachloride-Nickel-
Cobalt (DAB-Ni-Co) substrate solution (Liquid DAB-
Black Substrate Kit, Vector Labs, Burlingame, CA, USA)
until color developed, dehydrated and mounted. Using
an Olympus BX 61 light microscope the labelled poly-
morphonuclear leucocytes were identified by their posi-
tive staining and morphologically by their characteristic
bilobed nucleus. The sections were assessed at ×40 mag-
nification in five specific predefined regions which
included cingulate gyrus, parietal cortex, entorhinal cor-
tex and two striatal regions (medial and lateral) [9].
Intravital Microscopy
Intravital microscopy was performed through a closed
bone window in the anesthetized animal maintained at
36.5°C using a rectal temperature probe and heating
pad. Images were acquired after tail-vein injection of
FITC-dextran (MW 2000 kDa, 50 microlitres, 10 mg/
mL). FITC extravasation from the pial vasculature was
assessed every 5 minutes for 30 minutes with an expo-
sure time of 20 seconds per image. Parameters for con-
trast, brightness and gamma correction remained
unchanged throughout the measures.
Statistical Analysis
All data were analyzed by investigators blinded to the
experimental group. Data is presented as mean ± S.D.
Comparisons between groups for stroke volume, mean
infarct T1 value, KGd, IgG extravasation and PMN infil-
tration were assessed withao n e - w a yA N O V A .M R M I
contrast effects were assessed with a two-way ANOVA
with repeated measures. Animals demonstrating FITC
extravasation were documented and compared using the
Freeman-Halton extension of a Fisher’se x a c tt e s tf o r2
× 3 tables. A p value of less than 0.05 was considered
significant.
Results
Stroke injury and Selectin expression
All mice survived for 24 hours following stroke induced
by transient middle cerebral artery occlusion. Cortical
perfusion reductions during ischemia, measured using
laser doppler flowmetry (LDF) were similar between
groups with cortical perfusion decreasing to values of
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WT-Gd, P-selectin KO- Gd-Slex and P selectin KO-Gd
groups, respectively (n.s., P > 0.7, One-Way ANOVA).
During reperfusion the LDF measurements were again
similar between groups with values of 84%, 66%, 70%
and 111% baseline flow upon reperfusion for WT-Gd-
Slex, WT-Gd, P-selectin KO- Gd-Slex, and P selectin
KO-Gd groups, respectively (n.s., P = 0.3, One-Way
ANOVA).
All animals subjected to middle cerebral artery occlu-
sion had ischemic infarction within the striatum and
parietal cortex. Measurement of infarct size from MR
images demonstrated that there was no substantial dif-
f e r e n c ei nt h es i z eo ft h es t r o k eb e t w e e nt h ef o u r
experimental groups (figure 1A). T1 values, were
increased in the ischemic region, however, mean values
prior to contrast injection were similar between groups
(Figure 1B).
The amount of P-selectin (ng/mg of protein) was
determined in brain samples from brain ipsilateral and
contralateral to the ischemia. Mean values were as fol-
lows: for wild type animals, 6.4 ± 5.5 in the ipsilateral
cortex and 3.5 ± 1.9 in the contralateral cortex (N = 6);
for P-selectin knockouts, 0.19 ± 0.3 in the ipsilateral
cortex and 0.06 ± .08 in the contralateral cortex (N =
2); and for shams, 0.5 ± 0.2 in the ipsilateral cortex and
0.64 ± .09 in the contralateral cortex (N = 3). E-selectin
expression was also measured in samples of brain ipsi-
lateral and contralateral to the ischemia. Mean levels of
E-selectin in ng/mg of protein were: for wild type ani-
mals, 1.048 ± 1.47 in the ipsilateral cortex and 0.789 ±
0.73 in the contralateral cortex (N = 6); for P-selectin
knockout animals, 0.324 ± 0.28 in the ipsilateral cortex
and 0.150 ± 0.12 in the contralateral cortex (N = 6);
and, for sham animals 0.0005 ± .0001 in ipsilateral cor-
tex and 0. 00054 ± .00002 mean contralateral cortex (N
= 3). Therefore the expression of P-selectin in ipsilateral
cortex of wild type animals was significantly different
from ipsilateral cortex of sham animals (P < 0.001) with
a trend for an ipsilateral-contralateral differences. Simi-
larly the expression of E-selectin in ipsilateral cortex of
Ps e l e c t i nK Oa n i m a l sw a ss i g nificantly increased com-
pared to sham controls (P < 0.03).
Blood Brain Barrier Function and Targeted Contrast
Effects
Permeability of the BBB was first assessed using the
transfer constant for Gd-DTPA (Kgd)i n t ob r a i no fa
g r o u po fw i l d - t y p em i c ec o m p a r e dt oag r o u po fP -
selectin deficient mice (Figure 2). Mean KGd values were
greater in the ischemic cortex in wild-type mice com-
pared to P-selectin knockouts, demonstrating enhanced
BBB dysfunction in the former group.
Selectivity of contrast accumulation or binding was
also assessed by MRMI using Gd-DTPA-SleX and
monitoring T1 changes over 55 minutes in these ani-
mals. In knockout mice, there was a significant
decrease in (Δ T1 Stroke-Δ T1 Control Hemiphere) in
the Gd-DTPA-(sLe
X) group (n = 5) compared to Gd-
DTPA (n = 5) at 33, 44 and 55 minutes after injection
(Figure 3). No such difference could be identified in
wild-type animals administered either Gd-DTPA or
Figure 1 Effects of transient cerebral ischemia on mean infarct volume and mean cerebral.T 1. Twenty four hours following 30 min. of
middle cerebral artery occlusion infarct volumes (mean ± SD) were similar in wild-type mice (WT) or P-selectin knockout (KO) mice administered
either gadolinium-DTPA (Gd) or Gd-DTPA conjugated with sialyl Lewis X (sLex) (A). Also, shown are T1 values in the ischemic brain prior to
contrast administration. (mean ± SD) (B). Values were similar in all groups (n.s.).
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X)). Because the Sle
X conjugated con-
trast agent binds to both E and P-selectin and P-selec-
tin is essentially not expressed in the brain of KO
mice, these results suggest there is E-selectin-mediated
binding to endothelium of the conjugated contrast
agent following stroke.
Immunoglulin G or Dextran extravasation and
Polymorphonuclear Leukocyte Infiltration
IgG extravasation was evaluated in 4 sham surgery mice,
10 wild-type mice and 6 knockout mice (Figure 4A, B).
The mean contralateral - ipsilateral differences in optical
d e n s i t yw e r es i g n i f i c a n t l yh i g h e ri nt h ew i l d - t y p eg r o u p
than in either the sham surgery or knockout groups,
i n d i c a t i v eo fam o r es e v e r eB B Bi n j u r yi nt h ew i l d - t y p e
animals (p < 0.0001).
The infiltration of polymorphonuclear (PMN) leuko-
cytes into the brain indicated differences between
groups. In the WT mice (N = 7), the number of PMNs
in the ipsilateral hemisphere was significantly higher
than in those of the KO (N = 6), p < 0.001) and sham
mice (N = 4, p < 0.001) (Figure 4C).
Figure 2 Effect of transient focal cerebral ischemia on the transfer constant (KGd) for Gd-DTPA into brain. Shown in the upper panel (A)
are the Patlak Plots used to determine KGd. The y-axis in these plots is the ratio of the tissue concentration of contrast Ctiss(t), divided by the
arterial plasma concentration at that time, i.e. Ca(t)/(1-Hct), where Hct is the arterial hematocrit. The tissue concentration was determined from
measures of tissue T1 and the blood concentration was estimated from T1 in the sagittal sinus. The slope provides a measure of KGd. The lower
Panel (B) shows that mean KGd values for Gd-DTPA are less in P-selectin knockout animals compared to Wildtype controls. * P < 0.03, P-selectin
Knockouts compared to Wild type groups, ipsilaterally.
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gery mice, 9 wild-type and 5 knockout mice at 24 hours
after reperfusion (Figure 4D). Fluorescein isothiocyanate
(FITC)-dextran was injected and its extraluminal con-
centration monitored. Increased FITC fluorescence,
indicative of enhanced vascular permeability, was
observed by 30 minutes after FITC injection in 8/9 WT
mice (89%) and in 2/5 KO mice (40%) but in none of
the sham mice (0/4)(Fisher Exact 3 × 2 table, p =
0.002). The frequency of FITC extravasation for WT
mice was greater than WT sham animals (Fishers Exact
P<0 . 0 1 ) ,b u tt h e r ew a sn od ifference in frequency
between KO mice and WT sham (NS, P > 0.5). There
was a strong trend for more frequent FITC extravasa-
tion observed in WT mice compared to KO mice
(Fischer’s Exact two tailed test P < 0.095).
Discussion
Blood brain barrier impairment is a well-known marker
of secondary cerebral injury following acute stroke asso-
ciated with increases in a propensity for hemorrhagic
transformation in infarcted tissue. The novel and impor-
tant finding in the present study is that P-selectin
expression contributes to BBB dysfunction at 24 hours
after acute stroke, thus illustrating an expanded role of
endothelial dysfunction as a key process in the early
development of ischemic injury. In our study, early
endothelial activation was evident by detecting
significant cortical selectin expression whereas under
normal physiologic conditions neither cerebral P- or E-
selectin are detected in substantial amounts [13]. The
extravasation of Gd-DTPA in the wild-type but not
knockout mouse indicates that P-selectin expression is
associated with more severe BBB impairment, despite
similar infarct size between the two groups. Addition-
ally, the similar T1 values in wild-type and knockout
mice suggest comparable infarct water content and simi-
lar parenchymal injury severity [14]. Therefore, despite
similar infarct extent and indicators of parenchymal
injury, the E and/or P-selectin binding of Gd-DTPA-
(sLe
X) in the knockout mouse was confounded less by
BBB breakdown than in the wild-type mouse, and the
lack of substantial P-selectin expression in these animals
supports a possible E-selectin mediated target for the
Sialyl Lewis X conjugated contrast agent.
Although P-selectin expression on endothelial cell and
platelet membranes has been reported to be pivotal for
leukocyte recruitment during the early stroke period [1],
the role of selectin adhesion molecules in promoting
brain edema and BBB injury is unclear. Ruehl et al sug-
gested that P-selectin blockade with fucoidin resulted in
less brain edema at 24 hours after 4 hour middle cere-
bral artery occlusion [6]. In our study, there was evi-
dence that BBB injury was more severe in the wild-type
mouse as indicated by greater extravasation of Gd-
DTPA and a somewhat higher frequency for
Figure 3 Magnetic resonance molecular imaging with Gd-DTPA-(sLe
X). In knockout (KO) mice there was increasing effects of targeted
contrast Gd-DTPA-(sLe
X) on tissue T1 levels in the stroke compared to the contralateral control hemisphere not observed with non-targetted
contrast or Gd-DTPA. *P < 0.05 and **P < 0.01. In wild type (WT) animals the administration of Gd-DTPA-(sLe
X) or Gd-DTPA resulted in a
decrease in T1 in the stroke compared to contralateral control hemisphere in both groups but there no statistical difference between groups.
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sibility of differential contributions of selectins to BBB
damage. We also show that PMN infiltration into the
infarct region is greater in the wild-type animals than
the P-selectin knockout animals, implicating P-selectin
as a major contributor to PMN recruitment and ulti-
mately infiltration into the stroke region. Our prelimin-
ary data would also support the involvement of both P-
selectin and PMN migration in early BBB breakdown.
Further work will be required to elucidate the precise
molecular mechanisms involved.
Previous studies have demonstrated that while ICAM-
1 and E-selectin expression were necessary for neutro-
phil transmigration across a human brain microvessel
endothelial cell layer, antibody blockade of ICAM-1 did
not reduce vessel permeability to horseradish peroxidase
despite dramatically decreased neutrophil migration
[15]. This suggests different mechanisms involving
ICAM-1 and possibly other cellular adhesion molecules
underlie neutrophil migration and BBB injury. This dis-
sociation between neutrophil-mediated cerebral injury
and BBB dysfunction has also been demonstrated in
traumatic brain injury[16]. While neutrophil accumula-
tion and E-selectin expression appear to mediate blood
vessel permeability to some extent after trauma, similar
to our current results, mice deficient in both P-selectin
and ICAM-1 had less brain edema than wild-type mice,
suggesting that trauma-induced BBB injury is influenced
preferentially by specific neuroinflammatory markers.
Following cerebral ischemia/reperfusion, TNF-a levels
are increased within two hours [17], followed by a peak
in P-selectin expression at 6 hours and a later peak in
E-selectin expression between 6 and 12 hours [18]. BBB
breakdown after middle cerebral artery occlusion and
Figure 4 IgG extravasation and polymorphonuclear (PMN) leukocyte infiltration after acute stroke. The contralateral - ipsilateral difference
in IgG staining was greater in wild-type than in sham surgery or P-selectin-deficient mice (A), indicating more severe BBB injury in mice
expressing P-selectin (* p < 0.05 for wild-type vs. knockout (KO) mice). Also shown are representative sections stained for IgG
immunohistochemistry from sham, wild type and P selectin KO mice (B). Numbers PMN leukocytes was greater in ischemic brains of wild-type
animals compared to those in P-selectin deficient animals or shams (C) (* p < 0.05, vs sham). Representative intravital microscopy images of the
pial vessels obtained either immediately or 30 minutes after intravenous administration of FITC-dextran (2000 kDa) in a wild-type mouse or a P-
selectin knockout mouse at 24 hours after transient middle cerebral artery occlusion or a mouse subjected to sham surgery (D), FITC
extravasation is evident in the wild-type mouse expressing P-selectin but not in the P-selectin KO animal.
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reach its maximal extent by 24 hours [19]. The post-
stroke progressive sequence of TNF-a expression, selec-
tin upregulation and BBB injury suggests a chronological
link between these events. Although many stroke
patients present to emergency care at a time that is
beyond the therapeutic window for thrombolysis, there
remains the possibility of attenuating secondary cerebral
injury in these patients by protecting the BBB. The pre-
sent findings suggest a role for P-selectin as an early
mediator of BBB injury and suggest an additional ratio-
nale to develop anti-inflammatory P-selectin targeted
therapy to mitigate stroke-induced vascular injury.
T h ee v i d e n c et h a tPs e l e c t i nm a yb ei n v o l v e di n
increasing the size of the stroke lesion remains poorly
substantiated. In our study, although we were able to
demonstrate an effect of reduced BBB breakdown in P
selectin knockout animals, we were not able to show an
effect of reducing stroke volume. The literature that spe-
cifically addresses the issue of whether attenuating P-
selectin expression reduces infarct size is sparse. Con-
nolly et al [20] reported that isolated, purified, radiola-
belled neutrophils accumulated in post-ischemic brain
and that there were fewer neutrophils accumulating in
P-selectin-deficient mice. In a model of cerebral ische-
mia reperfusion, P-selectin knockout mice exhibited a
reduction in infarct volume, better functional outcome
and a better return of cerebral blood flow after ischemia
[20]. Similarly, blocking antibodies for P-selectin
reduced infarct size and hemorrhagic transition in ische-
mia reperfusion [21]. The results of these studies are at
least in part consistent with those observed presently
regarding the beneficial effects of reduced P-selectin
expression on BBB function. In moving towards clinical
translation, the role for P-selectin in ischemic injury
induced blood brain barrier dysfunction would need
confirmation in additional animal studies that demon-
strate the effectiveness on long-term and behavioural
outcomes of antagonising P-selectin expression for
example using either P-selectin antibody or P-selectin
peptide.
Conclusions
The results indicate that elevated P-selectin expression
following ischemia-reperfusion contributes to enhanced
BBB dysfunction at 24 hours after transient focal cere-
bral ischemia despite a lack of appreciable effect on
overall infarct volume.
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